Pacific Biosciences
PACB
PACB
227 hedge funds and large institutions have $1.03B invested in Pacific Biosciences in 2022 Q2 according to their latest regulatory filings, with 34 funds opening new positions, 87 increasing their positions, 62 reducing their positions, and 51 closing their positions.
Holders
227
Holders Change
-21
Holders Change %
-8.47%
% of All Funds
3.84%
Holding in Top 10
1
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-80%
% of All Funds
0.02%
New
34
Increased
87
Reduced
62
Closed
51
Calls
$7.59M
Puts
$9.38M
Net Calls
-$1.8M
Net Calls Change
-$7.46M
Top Buyers
1 |
1
Goldman Sachs
New York
|
$37.3M |
2 |
2
T. Rowe Price Associates
Baltimore,
Maryland
|
$45.5M |
3 |
3
Two Sigma Advisers
New York
|
$15.8M |
4 |
1WCM
4
12 West Capital Management
New York
|
$8.51M |
5 |
5
BlackRock
New York
|
$81.2M |